Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler
Background: Clinical studies on medical cannabis (MC) treatment have shown sex-related differences, including higher susceptibility to adverse events among women and greater analgesia among men. Here, we used the Syqe metered-dose inhaler (MDI) and a single chemovar to analyze sex differences. Metho...
Main Authors: | Joshua Aviram, Marek Glezerman, Eytan Hayam, Rostislav Belobrov, Shiri Procaccia, David Meiri, Elon Eisenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/10/1426 |
Similar Items
-
Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
by: Shiri Procaccia, et al.
Published: (2022-04-01) -
THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial
by: Joshua Aviram, et al.
Published: (2022-10-01) -
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
by: Joshua Aviram, et al.
Published: (2022-05-01) -
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020-09-01) -
Cannabis therapy in neurological disorders: Recent advances and perspectives
by: Alexandru Mandici, et al.
Published: (2020-12-01)